Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The therapeutic potential of erythropoietin receptor transgenes.

Cytokines, cellular & molecular therapy - 1 Jun 1999

Kirby S L

Abstract excerpt

Allogeneic bone marrow transplantation is an effective curative therapy for both malignant and heritable diseases. The use of genetically altered autologous hematopoietic stem cells (HSC) is being increasingly investigated as a treatment for a variety of non-malignant but significantly morbid diseases, including hemoglobinopathies, immunodeficiencies and autoimmune diseases. Other hematopoietic cells capable of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow Transplantation
Share to Cell Line
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematopoietic Stem Cell Transplantation

Share to Mice, Transgenic

Share to Receptors, Erythropoietin

Share to Transduction, Genetic

Source

Identifiers

PMID: 10515682

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The therapeutic potential of erythropoietin receptor transgenes.PMID 10515682Read ↗

Proliferation of multipotent hematopoietic cells controlled by a truncated erythropoietin receptor transgene.Semantic proximity Read ↗

Erythropoietin receptor signaling regulates both erythropoiesis and megakaryopoiesis in vivo.Semantic proximity Read ↗

Aberrant phenotypes of transgenic mice expressing dimeric human erythropoietin.Semantic proximity Read ↗

Targeted erythropoietin selectively stimulates red blood cell expansion in vivoSemantic proximity Read ↗

Tissue Specific Expression of Human Erythropoietin Receptor in Transgenic MiceSemantic proximity Read ↗

Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor.Semantic proximity Read ↗

Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice.Semantic proximity Read ↗

Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice.Semantic proximity Read ↗

Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primatesSemantic proximity Read ↗

Tissue-Specific Targeting of Retroviral Vectors Through Ligand-Receptor InteractionsSemantic proximity Read ↗

Survival and proliferative roles of erythropoietin beyond the erythroid lineageSemantic proximity Read ↗

A Truncated Erythropoietin Receptor That Fails to Prevent Programmed Cell Death of Erythroid CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.